Nauka innov. 2013, 9(2):99-103
https://doi.org/10.15407/scin9.02.099

V. Voyevoda, A. Derzhypolskyi, D. Melenevskyi
LTD "Innovations", Kyiv

Unique Analyzer Zetasizer Nano – 10 Reasons of Scientific Success

Section: The World of Innovations
Language: Ukrainian
Abstract: A brief overview of the current state of science areas dealing with nanomaterials, colloids and disperse systems is presented. Particular attention is given to the methods of research used in these areas. The role and importance of Zetasizer Nano series analytical instruments from Malvern Instruments Ltd in the scientific world are considered. The main success factors of Zetasizer Nano as a research tool are presented.
Key words: nanoparticles, zeta-potential, colloid systems, microrheology, biomolecules, dynamic lightscattering, molecular weight, Zetasizer Nano.

Full Text (PDF)

References:
1. Processable aqueous dispersions of graphene nanosheets. D Li, MB Müller, S Gilje, RB Kaner, GG Wallace. Nature Nanotechnology. 2008. No. 3. P. 101-105.
2. PEG-modified gold nanorods with a stealth character for in vivo applications. Takuro Niidome, Masato Yamagata, Yuri Okamoto, Yasuyuki Akiyama, Hironobu Takahashi, Takahito Kawano, Yoshiki Katayama, Yasuro Niidome. J. of Controlled Release. 2006. No. 114(3). P. 343-347.
3. Pulmonary toxicity study in rats with three forms of ultrafine TiO2 particles: differential responses related to surface properties. DB Warheit, TR Webb, KL Reed, S Frerichs, CM Sayes. Toxicology. 2007. No. 230 (1).  P. 90-104.
4. RNA Interference in Vitro and in Vivo Using a Chitosan/ siRNA Nanoparticle System. KA Howard, UL Rahbek, X Liu, CK Damgaard, SZ Glud, MØ Andersen, MB Hovgaard, A Schmitz, JR Nyengaard, F Besenbacher, J Kjems. Molecular Therapy. 2006. No. 14. P. 476-484.
5. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. CM Sayes, KL Reed, DB Warheit. Toxicological Sciences. 2007. No. 97(1). P. 163-180.
6. Preparation and antibacterial activity of chitosan na noparticles. L Qi, Z Xu, X Jiang, C Hu, X Zou. Carbohy drate Research. 2004. No. 339(16). P. 2693-2700.
7. Characterization of Nanomaterial Dispersion in Solution Prior to In Vitro Exposure Using Dynamic Light Scattering Technique. RC Murdock, L Braydich-Stolle, AM Schrand, J. Schlager and SM Hussain. Toxicological Sciences. 2008. No. 101(2). P. 239-253.
8. pH-Responsive copolymer assemblies for controlled re lease of doxorubicin. ER Gillies and JMJ Fréchet. Bioconjugate Chemistry. 2005. No. 16(2). P. 361-368.
9. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. DB Warheit, RA Hoke, C Finlay, EM Donner, KL Reed, CM Sayes. Toxicology Letters. 2007. No. 171(3). P. 99-110.
10. Preparation and adsorption properties of monodisperse chitosan-bound Fe3O4 magnetic nanoparticles for removal of Cu (II) ions. YC Chang, DH Chen. J. Of Colloid and Interface Science. 2005. No. 283(2). P. 446-451.